|
Section 81.0
|
Purpose and Authority |
|
Section 81.1
|
Provisions of EEOICPA concerning this part |
|
Section 81.2
|
Definition of terms used in this part |
|
Section 81.4
|
Use of personal and medical information |
|
Section 81.5
|
Use of radiation dose information |
|
Section 81.6
|
Use of cancer risk assessment models in NIOSH IREP |
|
Section 81.10
|
Use of uncertainty analysis in NIOSH-IREP |
|
Section 81.11
|
Procedure to update NIOSH-IREP |
|
Section 81.12
|
Required use of NIOSH-IREP |
|
Section 81.20
|
Cancers requiring the use of NIOSH-IREP |
|
Section 81.21
|
General guidelines for use of NIOSH-IREP |
|
Section 81.22
|
Guidelines for cancers for which primary site is unknown |
|
Section 81.23
|
Guidelines for leukemia |
|
Section 81.24
|
Guidelines for claims including two or more primary cancers |
|
Section 81.25
|
Background information on this part |